Published in Science on February 25, 2000
Drug resistance in leishmaniasis. Clin Microbiol Rev (2006) 7.35
Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol (2010) 6.18
Challenges of antibacterial discovery. Clin Microbiol Rev (2011) 3.94
Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog (2011) 3.89
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci U S A (2001) 3.42
Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother (2000) 3.27
Horizontal gene transfer: a critical view. Proc Natl Acad Sci U S A (2003) 3.27
Compensatory evolution in rifampin-resistant Escherichia coli. Genetics (2000) 2.96
Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother (2002) 2.55
Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2004) 2.53
Amelioration of the cost of conjugative plasmid carriage in Eschericha coli K12. Genetics (2003) 2.39
Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog (2006) 2.26
Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev (2002) 2.20
Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Chemother (2002) 2.07
Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc Natl Acad Sci U S A (2005) 2.04
Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet (2009) 2.02
The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proc Biol Sci (2009) 1.94
Fast growth increases the selective advantage of a mutation arising recurrently during evolution under metal limitation. PLoS Genet (2009) 1.89
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother (2003) 1.89
High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol (2002) 1.85
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus. Antimicrob Agents Chemother (2002) 1.79
The role of compensatory mutations in the emergence of drug resistance. PLoS Comput Biol (2006) 1.63
Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans. J Bacteriol (2001) 1.63
The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat Rev Genet (2010) 1.58
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob Agents Chemother (2007) 1.58
Jumping the barrier to beta-lactam resistance in Staphylococcus aureus. J Bacteriol (2003) 1.57
Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proc Natl Acad Sci U S A (2006) 1.56
The causes of epistasis. Proc Biol Sci (2011) 1.50
Crossing the line: selection and evolution of virulence traits. PLoS Pathog (2006) 1.49
Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother (2005) 1.47
In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol (2007) 1.46
Development of Saccharomyces cerevisiae as a model pathogen. A system for the genetic identification of gene products required for survival in the mammalian host environment. Genetics (2001) 1.46
Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proc Natl Acad Sci U S A (2010) 1.44
Mutator bacteria as a risk factor in treatment of infectious diseases. Antimicrob Agents Chemother (2002) 1.42
Tuberculosis: drug resistance, fitness, and strategies for global control. Eur J Pediatr (2007) 1.41
Experimental evolution with E. coli in diverse resource environments. I. Fluctuating environments promote divergence of replicate populations. BMC Evol Biol (2010) 1.30
Assessment of bacterial antibiotic resistance transfer in the gut. Int J Microbiol (2011) 1.26
23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A-->G. Proc Natl Acad Sci U S A (2005) 1.24
Pervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutations. PLoS Genet (2011) 1.22
Genetic analysis of colistin resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother (2009) 1.17
Stress-based identification and classification of antibacterial agents: second-generation Escherichia coli reporter strains and optimization of detection. Antimicrob Agents Chemother (2002) 1.17
Experimental adaptation of Salmonella typhimurium to mice. Genetics (2004) 1.13
Fusidic acid-resistant mutants of Salmonella enterica serovar Typhimurium with low fitness in vivo are defective in RpoS induction. Antimicrob Agents Chemother (2003) 1.13
Quinolone resistance due to reduced target enzyme expression. J Bacteriol (2003) 1.13
The fitness cost of streptomycin resistance depends on rpsL mutation, carbon source and RpoS (sigmaS). Genetics (2009) 1.13
The Base Excision Repair system of Salmonella enterica serovar typhimurium counteracts DNA damage by host nitric oxide. PLoS Pathog (2009) 1.12
Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa. Proc Biol Sci (2009) 1.10
Pre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitro. PLoS One (2012) 1.10
Different spectra of stationary-phase mutations in early-arising versus late-arising mutants of Pseudomonas putida: involvement of the DNA repair enzyme MutY and the stationary-phase sigma factor RpoS. J Bacteriol (2002) 1.09
The fitness costs of antibiotic resistance mutations. Evol Appl (2014) 1.08
Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya. Sci Rep (2013) 1.07
Antimicrobial drug resistance affects broad changes in metabolomic phenotype in addition to secondary metabolism. Proc Natl Acad Sci U S A (2013) 1.07
A shared population of epidemic methicillin-resistant Staphylococcus aureus 15 circulates in humans and companion animals. MBio (2014) 1.07
A fitness cost associated with the antibiotic resistance enzyme SME-1 beta-lactamase. Genetics (2007) 1.06
Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatment. PLoS One (2011) 1.06
Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host. Antimicrob Agents Chemother (2011) 1.05
Models to understand the population-level impact of mixed strain M. tuberculosis infections. J Theor Biol (2011) 1.04
Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2005) 1.04
Functional heterogeneity of RpoS in stress tolerance of enterohemorrhagic Escherichia coli strains. Appl Environ Microbiol (2006) 1.01
Compensation of fitness costs and reversibility of antibiotic resistance mutations. Antimicrob Agents Chemother (2010) 1.01
In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis. Antimicrob Agents Chemother (2005) 0.99
Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.99
Influence of antibiotic selection on genetic composition of Escherichia coli populations from conventional and organic dairy farms. Appl Environ Microbiol (2007) 0.99
Durable resistance: a key to sustainable management of pathogens and pests. Infect Genet Evol (2014) 0.99
The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase. Genetics (2011) 0.99
Compensatory evolution of pbp mutations restores the fitness cost imposed by β-lactam resistance in Streptococcus pneumoniae. PLoS Pathog (2011) 0.98
The evolution of plasmid-carried antibiotic resistance. BMC Evol Biol (2011) 0.98
Public health evolutionary biology of antimicrobial resistance: priorities for intervention. Evol Appl (2014) 0.97
Upgrading antibiotic use within a class: tradeoff between resistance and treatment success. Proc Natl Acad Sci U S A (2006) 0.96
Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study. PLoS One (2008) 0.96
Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections. PLoS One (2010) 0.95
Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymerase. Mol Microbiol (2014) 0.93
A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin. Antimicrob Agents Chemother (2012) 0.91
Emergence and spread of antibiotic resistance: setting a parameter space. Ups J Med Sci (2014) 0.90
Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium. Antimicrob Agents Chemother (2006) 0.90
Evidence of antibiotic resistance gene silencing in Escherichia coli. Antimicrob Agents Chemother (2006) 0.90
A trade-off between the fitness cost of functional integrases and long-term stability of integrons. PLoS Pathog (2012) 0.89
The TCA cycle is not required for selection or survival of multidrug-resistant Salmonella. J Antimicrob Chemother (2011) 0.89
Fitness costs of various mobile genetic elements in Enterococcus faecium and Enterococcus faecalis. J Antimicrob Chemother (2013) 0.88
The potential impact of coinfection on antimicrobial chemotherapy and drug resistance. Trends Microbiol (2015) 0.86
Age-related decline in carriage of ampicillin-resistant Escherichia coli in young calves. Appl Environ Microbiol (2004) 0.86
Structure and function of FusB: an elongation factor G-binding fusidic acid resistance protein active in ribosomal translocation and recycling. Open Biol (2012) 0.86
Lytic phages obscure the cost of antibiotic resistance in Escherichia coli. ISME J (2015) 0.84
Perspectives: microbiology. Mice are not furry petri dishes. Science (2000) 0.83
Use of mutator strains for characterization of novel antimicrobial agents. Antimicrob Agents Chemother (2001) 0.82
Engineering a portable riboswitch-LacP hybrid device for two-way gene regulation. Nucleic Acids Res (2011) 0.82
A central interdomain protein joint in elongation factor G regulates antibiotic sensitivity, GTP hydrolysis, and ribosome translocation. J Biol Chem (2011) 0.82
Adaptation of a plant pathogen to partial host resistance: selection for greater aggressiveness in grapevine downy mildew. Evol Appl (2016) 0.82
Evolutionary rescue by compensatory mutations is constrained by genomic and environmental backgrounds. Mol Syst Biol (2015) 0.81
The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa. Proc Biol Sci (2016) 0.80
Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health. Evol Appl (2015) 0.80
Costs of antibiotic resistance - separating trait effects and selective effects. Evol Appl (2014) 0.80
Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas. Proc Biol Sci (2016) 0.79
Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance. PLoS Comput Biol (2015) 0.79
Evolution of Resistance to Continuously Increasing Streptomycin Concentrations in Populations of Escherichia coli. Antimicrob Agents Chemother (2015) 0.79
Bayesian methods for fitting mixture models that characterize branching tree processes: An application to development of resistant TB strains. Stat Med (2011) 0.79
Can treatment increase the epidemic size? J Math Biol (2015) 0.79
Ecological and temporal constraints in the evolution of bacterial genomes. Genes (Basel) (2011) 0.78
A genomic and evolutionary approach reveals non-genetic drug resistance in malaria. Genome Biol (2014) 0.78
A model-guided analysis and perspective on the evolution and epidemiology of antibiotic resistance and its future. Curr Opin Microbiol (2014) 0.78
Selection of DNA binding sites by regulatory proteins. Statistical-mechanical theory and application to operators and promoters. J Mol Biol (1987) 17.53
Diffusion-driven mechanisms of protein translocation on nucleic acids. 1. Models and theory. Biochemistry (1981) 9.05
Medical student selection: a tentative attempt to establish a code of practice. Br Med J (1980) 7.21
Facilitated target location in biological systems. J Biol Chem (1989) 7.18
Lymphocyte transformation in vitro measured by tritiated thymidine uptake. I. Lymphocyte culture techniques. Int Arch Allergy Appl Immunol (1970) 5.67
Diffusion-driven mechanisms of protein translocation on nucleic acids. 3. The Escherichia coli lac repressor--operator interaction: kinetic measurements and conclusions. Biochemistry (1981) 5.28
Diffusion-controlled macromolecular interactions. Annu Rev Biophys Biophys Chem (1985) 4.87
Stochastic focusing: fluctuation-enhanced sensitivity of intracellular regulation. Proc Natl Acad Sci U S A (2000) 4.32
Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci U S A (1998) 4.28
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature (1991) 3.86
Consultation length and outcome in two group general practices. J R Coll Gen Pract (1983) 3.76
Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Engl J Med (1993) 3.55
A model for the statistical fluctuations of protein numbers in a microbial population. J Theor Biol (1978) 3.42
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci U S A (2001) 3.42
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20
On the specificity of DNA-protein interactions. Proc Natl Acad Sci U S A (1986) 3.11
Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol (2001) 2.94
Orientation constraints in diffusion-limited macromolecular association. The role of surface diffusion as a rate-enhancing mechanism. Biophys J (1985) 2.82
Paper and people: the work of the casualty reception clerk. Sociol Health Illn (1989) 2.54
Prospective analysis of stoma-related complications. Colorectal Dis (2005) 2.35
Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med (1991) 2.34
Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol (2001) 2.30
The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med (1997) 2.28
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Bacterial genome size reduction by experimental evolution. Proc Natl Acad Sci U S A (2005) 2.13
Association kinetics with coupled diffusional flows. Special application to the lac repressor--operator system. Biophys Chem (1976) 2.13
Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature (1993) 2.04
RCPE UK consensus statement on diabetes. J R Coll Physicians Edinb (2010) 2.03
The control region of the pdu/cob regulon in Salmonella typhimurium. J Bacteriol (1994) 2.00
Comparison of sevoflurane and propofol with rocuronium for modified rapid-sequence induction of anaesthesia. Anaesthesia (1999) 1.98
Translation rates and misreading characteristics of rpsD mutants in Escherichia coli. Mol Gen Genet (1982) 1.95
Prevalence of celiac disease and its endoscopic markers among patients having routine upper gastrointestinal endoscopy. Am J Gastroenterol (1999) 1.93
Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J Mol Biol (2000) 1.78
Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol (1999) 1.77
Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol Microbiol (1999) 1.75
Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci (1994) 1.74
Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium. Gene (1994) 1.74
Selection of DNA binding sites by regulatory proteins. Trends Biochem Sci (1988) 1.73
Lateral spine radiographs before androgen deprivation treatment detect a high incidence of undiagnosed vertebral fragility fractures in men with advanced prostate cancer. J Urol (2011) 1.72
Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth (1999) 1.69
Head injuries: a study evaluating the impact of the NICE head injury guidelines. Emerg Med J (2005) 1.66
The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood (1998) 1.66
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet (2005) 1.63
Muller's ratchet decreases fitness of a DNA-based microbe. Proc Natl Acad Sci U S A (1996) 1.63
Isolation of Yersinia enterocolitica from milk and a dairy farm in Australia. J Appl Bacteriol (1979) 1.63
The kinetics of interfacial catalysis by phospholipase A2 and regulation of interfacial activation: hopping versus scooting. Biochim Biophys Acta (1989) 1.62
Association kinetics with coupled diffusion III. Ionic-strength dependence of the lac repressor-operator association. Biophys Chem (1978) 1.58
Lack of mature B cells in nude mice with X-linked immune deficiency. J Exp Med (1982) 1.52
Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother (2009) 1.51
Cobalamin (vitamin B12) repression of the Cob operon in Salmonella typhimurium requires sequences within the leader and the first translated open reading frame. Mol Microbiol (1992) 1.51
Increased cholecystectomy rate in the laparoscopic era: a study of the potential causative factors. Surg Endosc (2006) 1.50
Community health monitoring: taking the pulse of America's children. Matern Child Health J (1998) 1.47
Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. Lancet (1968) 1.46
Activated ras oncogenes in human thyroid cancers. Cancer Res (1988) 1.45
Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology (1994) 1.43
Homologous recombination between the tuf genes of Salmonella typhimurium. J Mol Biol (1996) 1.43
Clinical trial of iron therapy of psychomotor function in anaemic women. Br Med J (1970) 1.41
Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol (1968) 1.41
Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J (2001) 1.41
Low-dose clonidine infusion during labour. Br J Anaesth (1999) 1.40
Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis. Lupus (1995) 1.39
Is midwifery safe in the embrace of the UKCC? Midwives (1995) (1995) 1.38
Benign vaginal polyp: a histological, histochemical and immunohistochemical study of 20 polyps with comparison to normal vaginal subepithelial layer. Histopathology (1992) 1.38
Sequence heterogeneity and anomalous electrophoretic mobility of kinetoplast minicircle DNA from Leishmania tarentolae. Gene (1984) 1.36
Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases. Lancet (1968) 1.36
Explaining oropharyngeal dysphagia after unilateral hemispheric stroke. Lancet (1997) 1.36
Association kinetics with coupled three- and one-dimensional diffusion. Chain-length dependence of the association rate of specific DNA sites. Biophys Chem (1982) 1.32
Vitamin B12 repression of the cob operon in Salmonella typhimurium: translational control of the cbiA gene. Mol Microbiol (1994) 1.31
Phylogenetic characterization of epibiotic bacteria in the accessory nidamental gland and egg capsules of the squid Loligo pealei (Cephalopoda:Loliginidae). Environ Microbiol (2001) 1.31
The effects of cytokines and growth factors on osteoblastic cells. Bone (1995) 1.28
Salmonella typhimurium mutants that downregulate phagocyte nitric oxide production. Cell Microbiol (2000) 1.28
Doctors' and nurses' perceptions of ethical problems in end-of-life decisions. J Adv Nurs (2001) 1.28
An adenosyl-cobalamin (coenzyme-B12)-repressed translational enhancer in the cob mRNA of Salmonella typhimurium. Mol Microbiol (2001) 1.27
Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2. Annu Rev Biochem (1995) 1.26
Lymphocyte transformation using whole blood cultures: an analysis of responses. J Immunol Methods (1972) 1.26
Suboptimal growth with hyper-accurate ribosomes. Arch Microbiol (1986) 1.25
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia (2008) 1.25
Extended preservation of non-heart-beating donor livers with normothermic machine perfusion. Br J Surg (2002) 1.25
Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor. Antimicrob Agents Chemother (2009) 1.25
Vitamin B12 repression of the btuB gene in Salmonella typhimurium is mediated via a translational control which requires leader and coding sequences. Mol Microbiol (1997) 1.25
Diffusion-controlled protein-DNA association: influence of segmental diffusion of the DNA. Biopolymers (1984) 1.24
BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer (2012) 1.24
The calibration of a whole-body radioactivity counter for the measurement of body potassium content in clinical studies. Clin Sci (1967) 1.24
Lymphocyte sensitivity to encephalitogenic factor in guinea pigs with experimental allergic encephalomyelitis as shown by in vitro inhibition of macrophage migration. Int Arch Allergy Appl Immunol (1968) 1.21
A technique for rapid isolation of macrophages from guinea-pig peritoneal exudates. J Clin Pathol (1970) 1.21
Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer. Cancer (1972) 1.19
Specific inhibitory action of polyunsaturated fatty acids on lymphocyte transformation induced by PHA and PPD. Int Arch Allergy Appl Immunol (1975) 1.18
Comparison of the traditional paper visual analogue scale questionnaire with an Apple Newton electronic appetite rating system (EARS) in free living subjects feeding ad libitum. Eur J Clin Nutr (1998) 1.18
Macrophages in tissues and in vitro. Curr Opin Immunol (1992) 1.17
Ram ribosomes are defective proofreaders. Mol Gen Genet (1983) 1.16
Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res (1987) 1.16
Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection. Br J Cancer Suppl (1973) 1.15
On the mode of action of antilymphocytic serum: experiments on electrophoretic mobility of macrophages in experimental allergic encephalomyelitis. Clin Exp Immunol (1970) 1.15
Growth and translation elongation rate are sensitive to the concentration of EF-Tu. Mol Microbiol (1993) 1.15
Diversifying microbial natural products for drug discovery. Appl Microbiol Biotechnol (2003) 1.13